Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients.
Pieck AC, Drescher A, Wiesmann KG, Messerschmidt J, Weber G, Strumberg D, Hilger RA, Scheulen ME, Jaehde U. Pieck AC, et al. Among authors: drescher a. Br J Cancer. 2008 Jun 17;98(12):1959-65. doi: 10.1038/sj.bjc.6604387. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18506148 Free PMC article. Clinical Trial.
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.
Lentz F, Drescher A, Lindauer A, Henke M, Hilger RA, Hartinger CG, Scheulen ME, Dittrich C, Keppler BK, Jaehde U; Central European Society for Anticancer Drug Research-EWIV. Lentz F, et al. Among authors: drescher a. Anticancer Drugs. 2009 Feb;20(2):97-103. doi: 10.1097/CAD.0b013e328322fbc5. Anticancer Drugs. 2009. PMID: 19209025 Clinical Trial.
Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors--a CESAR study (Central European Society for Anticancer Drug Research--EWIV).
Hofheinz RD, Dittrich C, Jakupec MA, Drescher A, Jaehde U, Gneist M, Graf von Keyserlingk N, Keppler BK, Hochhaus A. Hofheinz RD, et al. Among authors: drescher a. Int J Clin Pharmacol Ther. 2005 Dec;43(12):590-1. doi: 10.5414/cpp43590. Int J Clin Pharmacol Ther. 2005. PMID: 16372529 Clinical Trial. No abstract available.
The cool brown dwarf Gliese 229 B is a close binary.
Xuan JW, Mérand A, Thompson W, Zhang Y, Lacour S, Blakely D, Mawet D, Oppenheimer R, Kammerer J, Batygin K, Sanghi A, Wang J, Ruffio JB, Liu MC, Knutson H, Brandner W, Burgasser A, Rickman E, Bowens-Rubin R, Salama M, Balmer W, Blunt S, Bourdarot G, Caselli P, Chauvin G, Davies R, Drescher A, Eckart A, Eisenhauer F, Fabricius M, Feuchtgruber H, Finger G, Förster Schreiber NM, Garcia P, Genzel R, Gillessen S, Grant S, Hartl M, Haußmann F, Henning T, Hinkley S, Hönig SF, Horrobin M, Houllé M, Janson M, Kervella P, Kral Q, Kreidberg L, Le Bouquin JB, Lutz D, Mang F, Marleau GD, Millour F, More N, Nowak M, Ott T, Otten G, Paumard T, Rabien S, Rau C, Ribeiro DC, Sadun Bordoni M, Sauter J, Shangguan J, Shimizu TT, Sykes C, Soulain A, Spezzano S, Straubmeier C, Stolker T, Sturm E, Subroweit M, Tacconi LJ, van Dishoeck EF, Vigan A, Widmann F, Wieprecht E, Winterhalder TO, Woillez J. Xuan JW, et al. Among authors: drescher a. Nature. 2024 Oct;634(8036):1070-1074. doi: 10.1038/s41586-024-08064-x. Epub 2024 Oct 16. Nature. 2024. PMID: 39415016
Trimeric Bet v 1-specific nanobodies cause strong suppression of IgE binding.
Bauernfeind C, Zettl I, Ivanova T, Goryainova O, Weijler AM, Pranz B, Drescher A, Focke-Tejkl M, Pavkov-Keller T, Eckl-Dorna J, Tillib SV, Flicker S. Bauernfeind C, et al. Among authors: drescher a. Front Immunol. 2024 May 3;15:1343024. doi: 10.3389/fimmu.2024.1343024. eCollection 2024. Front Immunol. 2024. PMID: 38784378 Free PMC article.
74 results